Belinostat

Scientific Overview: Pan-HDAC inhibitor; approved PTCL 2014; combined with CHOP. T-cell lymphoma HDAC inhibitor

Mechanism of Action: Pan-HDAC Inhibitor

Purity: ≥99%  |  Molecular Formula: C15H13N3O4S

For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.